Savvy Stock Picks

Bucyrus International, Inc. (Public, NASDAQ:BUCY) increased 0.02%, currently trading at $89.47 and its overall traded volume was 116,932.00 shares while reporting at 10:30 AM against its average volume of 3.83M. BUCY opened the day at $89.46, it made an intraday low of $89.46 and an intraday high of $89.55. The stock has a 52 week low of $45.03 and 52 week high of $90.21. BUCY’s market capitalization is 7.25B and it has 81.01M outstanding shares.

About Bucyrus International, Inc. (Public, NASDAQ:BUCY)
Bucyrus International, Inc. (Bucyrus) is a designer and manufacturer of safe and mining equipment for the extraction of coal, copper, oil sands, iron ore and other minerals in mining centers throughout the world. In addition to the manufacture of original equipment, Bucyrus also provides the aftermarket replacement parts and service for this equipment. Bucyrus operates in two business segments: surface mining, including the principal products of Terex Mining, and underground mining. All of its products and services are marketed under the Bucyrus name. The Company has manufacturing facilities in Australia, China, the Czech Republic, Germany, Mexico, the United Kingdom and the United States, and service and sales centers in Australia, Brazil, Canada, Chile, China, England, India, Indonesia, Mexico, Peru, Russia, South Africa and the United States. On February 19, 2010, Bucyrus completed the acquisition of Terex Corporation, the mining equipment business.

---

Cytokinetics, Inc. (Public, NASDAQ:CYTK) increased 0.00%, currently trading at $2.13 and its overall traded volume was 125,315.00 shares while reporting at 10:30 AM against its average volume of 644,598.00. CYTK opened the day at $2.15, it made an intraday low of $2.12 and an intraday high of $2.17. The stock has a 52 week low of $2.01 and 52 week high of $3.78. CYTK’s market capitalization is 140.32M and it has 65.88M outstanding shares.

About Cytokinetics, Inc. (Public, NASDAQ:CYTK)
Cytokinetics, Incorporated (Cytokinetics) is a biopharmaceutical company focused on the discovery and development of small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. The Company’s research and development programs relating to the biology of muscle function are directed to small molecule modulators of the contractility of cardiac, skeletal and smooth muscle. The cardiac muscle contractility program is focused on cardiac muscle myosin, a motor protein that powers cardiac muscle contraction. The drug candidate from this program, CK-1827452, is a cardiac muscle myosin activator. In January 2009, the Company announced the selection of a potential drug candidate that modulates smooth muscle contractility. This compound is a direct inhibitor of smooth muscle myosin, the motor protein central to the contraction of smooth muscle that causes the relaxation of contracted smooth muscle.

---

Cathay General Bancorp (Public, NASDAQ:CATY) increased 1.97%, currently trading at $16.54 and its overall traded volume was 124,214.00 shares while reporting at 10:30 AM against its average volume of 670,991.00. CATY opened the day at $16.26, it made an intraday low of $16.08 and an intraday high of $16.58. The stock has a 52 week low of $7.36 and 52 week high of $16.58. CATY’s market capitalization is 1.30B and it has 78.53M outstanding shares.

About Cathay General Bancorp (Public, NASDAQ:CATY)
Cathay General Bancorp (Bancorp) is a holding company of Cathay Bank, a California state-chartered commercial bank (the Bank). It also owns 100% of the common stock of five statutory business trusts created for the purpose of issuing capital securities. The Company’s subsidiaries include Cathay Capital Trust I, Cathay Statutory Trust I, Cathay Capital Trust II, Cathay Capital Trust III, Cathay Capital Trust IV and GBC Venture Capital, Inc. As a commercial bank, the Bank accepts checking, savings, and time deposits, and makes commercial, real estate, personal, home improvement, automobile, and other installment and term loans. The Bank provides letters of credit, wire transfers, forward currency spot and forward contracts, traveler’s checks, safe deposit, night deposit, Social Security payment deposit, collection, bank-by-mail, drive-up and walk-up windows, automatic teller machines (ATM), Internet banking services and other customary bank services.

---

Conexant Systems, Inc. (Public, NASDAQ:CNXT) decreased -0.61%, currently trading at $1.62 and its overall traded volume was 117,890.00 shares while reporting at 10:30 AM against its average volume of 969,552.00. CNXT opened the day at $1.64, it made an intraday low of $1.60 and an intraday high of $1.64. The stock has a 52 week low of $1.32 and 52 week high of $5.17. CNXT’s market capitalization is 132.94M and it has 82.06M outstanding shares.

About Conexant Systems, Inc. (Public, NASDAQ:CNXT)
Conexant Systems, Inc. (Conexant) designs, develops and sells semiconductor system solutions, consist of semiconductor devices, software and reference designs, for imaging, audio, embedded-modem, and video applications. These solutions include a portfolio of imaging solutions for multifunction printers (MFPs), fax platforms, and interactive display frame market segments. Its audio solutions include high-definition (HD) audio integrated circuits, HD audio codecs, and speakers-on-a-chip solutions for personal computers (PC), PC peripheral sound systems, audio subsystems, speakers, notebook docking stations, voice-over Internet protocol (VoIP) speakerphones, universal serial bus (USB) headsets supporting Microsoft Office Communicator and Skype, and audio-enabled surveillance applications. It also offers a range of embedded-modem solutions for set-top boxes, point-of-sale systems, home automation and security systems, and desktop and notebook PCs.

---

Prospect Capital Corporation (Public, NASDAQ:PSEC) increased 0.38%, currently trading at $10.69 and its overall traded volume was 128,081.00 shares while reporting at 10:30 AM against its average volume of 1.10M. PSEC opened the day at $10.65, it made an intraday low of $10.63 and an intraday high of $10.70. The stock has a 52 week low of $8.85 and 52 week high of $13.22. PSEC’s market capitalization is 891.80M and it has 83.42M outstanding shares.

About Prospect Capital Corporation (Public, NASDAQ:PSEC)
Prospect Capital Corporation (Prospect Capital) is a financial services company that lends to and invests in middle market privately-held companies. The Company is a closed-end investment company. The Company invests primarily in senior and subordinated debt and equity of companies in need of capital for acquisitions, divestitures, growth, development, project financing and recapitalization. The Company’s investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. It focuses on making investments in private companies, and many of its investments are in energy companies. The Company’s investment adviser is Prospect Capital Management LLC. On December 2, 2009, the Company completed the acquisition of Patriot Capital Funding, Inc. (Patriot), whereby Patriot merged with and into the Company.

---